🚀 VC round data is live in beta, check it out!

Lumexa Imaging Valuation Multiples

Discover revenue and EBITDA valuation multiples for Lumexa Imaging and similar public comparables like Guangzhou Wondfo Biotech, Daan Gene, Ramsay Santé, Vimian Group and more.

Lumexa Imaging Overview

About Lumexa Imaging

Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists’ interpretations of those studies.


Founded

2025

HQ

United States

Employees

5.0K

Financials (LTM)

Revenue: $1B
EBITDA: $232M

EV

$3B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Lumexa Imaging Financials

Lumexa Imaging reported last 12-month revenue of $1B and EBITDA of $232M.

In the same LTM period, Lumexa Imaging generated $165M in gross profit, $232M in EBITDA, and had net loss of ($19M).


Lumexa Imaging P&L

In the most recent fiscal year, Lumexa Imaging reported revenue of $949M and EBITDA of $114M.

Lumexa Imaging expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Lumexa Imaging forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$1BXXX$949MXXXXXXXXX
Gross Profit$165MXXX$96MXXXXXXXXX
Gross Margin16%XXX10%XXXXXXXXX
EBITDA$232MXXX$114MXXXXXXXXX
EBITDA Margin22%XXX12%XXXXXXXXX
EBIT Margin11%XXX(2%)XXXXXXXXX
Net Profit($19M)XXX($94M)XXXXXXXXX
Net Margin(2%)XXX(10%)XXXXXXXXX
Net Debt——$1BXXXXXXXXX

Financial data powered by Morningstar, Inc.

Lumexa Imaging Stock Performance

Lumexa Imaging has current market cap of $1B, and enterprise value of $3B.


Lumexa Imaging's stock price is $14.13.

See Lumexa Imaging trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$1B0.0%XXXXXXXXX$-1.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Lumexa Imaging Valuation Multiples

Lumexa Imaging trades at 2.6x EV/Revenue multiple, and 11.4x EV/EBITDA.

See valuation multiples for Lumexa Imaging and 15K+ public comps

Lumexa Imaging Financial Valuation Multiples

As of March 29, 2026, Lumexa Imaging has market cap of $1B and EV of $3B.

Equity research analysts estimate Lumexa Imaging's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Lumexa Imaging has a P/E ratio of (70.4x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$1BXXX$1BXXXXXXXXX
EV (current)$3BXXX$3BXXXXXXXXX
EV/Revenue2.6xXXX2.8xXXXXXXXXX
EV/EBITDA11.4xXXX23.2xXXXXXXXXX
EV/EBIT22.6xXXX(162.6x)XXXXXXXXX
EV/Gross Profit16.1xXXX27.5xXXXXXXXXX
P/E(70.4x)XXX(14.2x)XXXXXXXXX
EV/FCF128.5xXXX204.6xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Lumexa Imaging Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Lumexa Imaging Margins & Growth Rates

Lumexa Imaging's revenue in the last 12 month grew by 5%.

Lumexa Imaging's revenue per employee in the last FY averaged $0.2M.

Lumexa Imaging's rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Lumexa Imaging's rule of X is 34% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Lumexa Imaging and other 15K+ public comps

Lumexa Imaging Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth5%XXX8%XXXXXXXXX
EBITDA Margin22%XXX12%XXXXXXXXX
EBITDA Growth5%XXX102%XXXXXXXXX
Rule of 40—XXX27%XXXXXXXXX
Bessemer Rule of X—XXX34%XXXXXXXXX
Revenue per Employee—XXX$0.2MXXXXXXXXX
G&A Expenses to Revenue5%XXX7%XXXXXXXXX
Opex to Revenue—XXX12%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Lumexa Imaging Public Comps

See public comps and valuation multiples for other Medical Imaging & Diagnostics comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Guangzhou Wondfo BiotechXXXXXXXXXXXXXXXXXX
Daan GeneXXXXXXXXXXXXXXXXXX
Ramsay SantéXXXXXXXXXXXXXXXXXX
Vimian GroupXXXXXXXXXXXXXXXXXX
NeoGenomicsXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Lumexa Imaging M&A Activity

Lumexa Imaging acquired XXX companies to date.

Last acquisition by Lumexa Imaging was on XXXXXXXX, XXXXX. Lumexa Imaging acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Lumexa Imaging

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Lumexa Imaging Investment Activity

Lumexa Imaging invested in XXX companies to date.

Lumexa Imaging made its latest investment on XXXXXXXX, XXXXX. Lumexa Imaging invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Lumexa Imaging

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Lumexa Imaging

When was Lumexa Imaging founded?Lumexa Imaging was founded in 2025.
Where is Lumexa Imaging headquartered?Lumexa Imaging is headquartered in United States.
How many employees does Lumexa Imaging have?As of today, Lumexa Imaging has over 5K employees.
Is Lumexa Imaging publicly listed?Yes, Lumexa Imaging is a public company listed on Nasdaq.
What is the stock symbol of Lumexa Imaging?Lumexa Imaging trades under LMRI ticker.
When did Lumexa Imaging go public?Lumexa Imaging went public in 2025.
Who are competitors of Lumexa Imaging?Lumexa Imaging main competitors are Guangzhou Wondfo Biotech, Daan Gene, Ramsay Santé, Vimian Group.
What is the current market cap of Lumexa Imaging?Lumexa Imaging's current market cap is $1B.
What is the current revenue of Lumexa Imaging?Lumexa Imaging's last 12 months revenue is $1B.
What is the current revenue growth of Lumexa Imaging?Lumexa Imaging revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of Lumexa Imaging?Current revenue multiple of Lumexa Imaging is 2.6x.
Is Lumexa Imaging profitable?Yes, Lumexa Imaging is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Lumexa Imaging?Lumexa Imaging's last 12 months EBITDA is $232M.
What is Lumexa Imaging's EBITDA margin?Lumexa Imaging's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of Lumexa Imaging?Current EBITDA multiple of Lumexa Imaging is 11.4x.
What is the current FCF of Lumexa Imaging?Lumexa Imaging's last 12 months FCF is $21M.
What is Lumexa Imaging's FCF margin?Lumexa Imaging's last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of Lumexa Imaging?Current FCF multiple of Lumexa Imaging is 128.5x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial